Search
“fda”
More pages from the web
151–155 of 1,179-
prostate-cancer.org
Content | Prostate Cancer Research Institute -- Education, Awareness and Research
HOMEABOUT USDECISION AIDERESOURCESNEWS & EVENTSINSIGHTSCONTACT USSEARCH Announcements Cabazitaxel, Jevtana Approved by FDA for metastatic HRPC previously treated with docetaxel.  Provenge Approved by FDA for the treatment of asymptomatic or minimally
-
spacetransportation.org
Spacetransportation
Spacetransportation Just another WordPress weblog Will Transcranial Magnetic Stimulation Get FDA Approval? September 12th, 2008 Neuronetics had tried last year (Jan 2007) to get FDA approval for its transcranial magnetic stimulation (TMS) device, but fai
-
stridesarco.com
..:: Welcome to STRIDES
News Strides Arcolab Announces US FDA Approval of Sumatriptan Succinate Injection. more... Strides Arcolab Announces US FDA Approval of Rocuronium Bromide Injection. more... An Overview: Established in'
-
dailyrx.com
www.dailyrx.com | Your prescription for actionable health news
top nav menu Home ConditionsAllergies Arthritis Asthma Cardiovascular Cancer Concussions Emphysema Eye Diseases Gastrointestinal Disorders Diabetes - Type 1 Diabetes - Type 2 Heart Attack Immunizations Infectious Diseases Kidney Diseases Kidney Failure Men's Health Neuromuscular Diseases Obesity OBGYN Patient-Safety & Education Pediatrics Rheumatoid Arthritis Scleroderma Trauma Women's Health MedicationsClinical Trials FDA Alerts FDA Approvals Natural Medicine OTC News
-
stocknucleus.blogspot.com
Stock Nucleus
Stock Nucleus Providing Stock Market and Public Company Information SearchADS Wednesday, January 26, 2011 What Will Happen to Mannkind? The FDA has sent MNKD a complete response letter for Affrezza asking for 2 more trials. The trial will involve type 1 and type 2 diabetics and the goal is to compare Mannkind?s new inhaler to the original inhaler that was used in prior studies. If MNKD can complete the trials Affrezza has a great chance at being approved by the FDA. During the conference